N-(4-(4-((3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)phenyl)acetamide

ID: ALA3763983

Chembl Id: CHEMBL3763983

PubChem CID: 127040247

Max Phase: Preclinical

Molecular Formula: C32H34N4O4S2

Molecular Weight: 602.78

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1ccc(Oc2ccc(/C=C3\SC(=S)N(c4ccc(OCCCN5CCN(C)CC5)cc4)C3=O)cc2)cc1

Standard InChI:  InChI=1S/C32H34N4O4S2/c1-23(37)33-25-6-12-29(13-7-25)40-28-10-4-24(5-11-28)22-30-31(38)36(32(41)42-30)26-8-14-27(15-9-26)39-21-3-16-35-19-17-34(2)18-20-35/h4-15,22H,3,16-21H2,1-2H3,(H,33,37)/b30-22-

Standard InChI Key:  SFPDRNYPUILMPY-SWKFRHMKSA-N

Alternative Forms

  1. Parent:

    ALA3763983

    ---

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 602.78Molecular Weight (Monoisotopic): 602.2021AlogP: 5.86#Rotatable Bonds: 10
Polar Surface Area: 74.35Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.13CX LogD: 4.34
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.18Np Likeness Score: -1.58

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source